| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $0.4B | $0.4B | $0.4B | $0.4B | $0.3B | $0.3B | $0.2B | $0.2B |
| Operating Income | $-0.2B | $0.4B | $0.5B | $0.5B | $0.5B | $0.5B | $0.1B | $0.1B |
| Net Income | $-0.4B | $0.0B | $0.3B | $0.2B | $0.3B | $0.3B | $0.1B | $0.0B |
| EPS (Basic) | $-63.21 | $2.58 | $47.34 | $39.73 | $48.49 | $51.73 | $9.43 | $7.40 |
| EPS (Diluted) | $-63.21 | $3.43 | $45.14 | $38.06 | $46.49 | $51.27 | $9.32 | $7.34 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $5.6B | $6.5B | $6.8B | $6.9B | $7.0B | $4.5B | $3.2B | $2.3B |
| Current Assets | $0.3B | $0.3B | $0.3B | $0.3B | $0.5B | $0.7B | $0.2B | $0.3B |
| Cash & Equivalents | $0.2B | $0.2B | $0.2B | $0.2B | $0.4B | $0.6B | $0.1B | $0.3B |
| Total Liabilities | $4.2B | $4.7B | $5.0B | $5.2B | $5.2B | $3.0B | $2.3B | $1.5B |
| Current Liabilities | $0.8B | $0.2B | $0.2B | $0.2B | $0.3B | $0.2B | $0.2B | $0.1B |
| Stockholders' Equity | $1.4B | $1.8B | $1.9B | $1.8B | $1.8B | $1.5B | $0.8B | $0.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.6B | $0.7B | $0.7B | $0.7B | $0.7B | $0.6B | $0.5B | $0.4B |
| Investing Cash Flow | $-0.2B | $-0.6B | $-0.3B | $-0.4B | $-2.5B | $-1.0B | $-1.1B | $-0.2B |
| Capital Expenditures | $0.3B | $0.3B | $0.4B | $0.4B | $0.4B | $0.3B | $0.3B | $0.2B |
| Financing Cash Flow | $-0.4B | $-0.1B | $-0.3B | $-0.5B | $1.6B | $0.8B | $0.5B | $-0.1B |